MDS 2020 | Atypical Parkinsonisms: clinical overview & challenges

Carlo Colosimo, MD, Santa Maria University Hospital, Terni, Italy, discusses the current landscape of atypical Parkinsonisms, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Although therapeutic options are still limited, translational research and clinical trials into disease-modifying strategies have accelerated. Additionally, Dr Colosimo outlines the most significant controversies in atypical Parkinsonisms, such as the differential diagnosis. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).